G.I. Windows

G.I. Windows

Verified
Non-surgical treatment of type-2 diabetes and obesity, by creating endo-luminal anastomoses that bypass portions of the GI tract.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$82m (Public information from Jun 2022)
West Bridgewater Massachusetts (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

$0.0

round
N/A

$0.0

round
investor

$0.0

round
investor investor

$0.0

round
investor investor investor investor

$0.0

round
*
N/A

$14.5m

Valuation: $82.0m

Early VC
Total Funding000k

Recent News about G.I. Windows

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.